Comparative evaluation of hypolipidemic activity of some marketed herbal formulations in triton induced hyperlipidemic rats

Pharmacologyonline

Volumn 3, Issue , 2007, Pages 211-221

  Kanungo, Sunil K ^a   Panda, D S ^a   Swain, S R ^a   Barik, B B ^b   Tripathi, D K ^c  

^a INSTITUTE OF PHARMACY AND TECHNOLOGY   (India)

^b UTKAL UNIVERSITY   (India)

^c Bengal School of Technology   (India)

Author keywords

Herbal formulation; Hypolipidemic

Indexed keywords

AEGLE MARMELOS EXTRACT; ASPHALTUM PUNJABIUM EXTRACT; AYURVEDIC DRUG; BLACK PEPPER EXTRACT; BOERHAAVIA DIFFUSA EXTRACT; CHOLESTEROL; CYAMPOSIS PSORALIODES EXTRACT; EMBELIA RIBES EXTRACT; GARCINIA CAMBOGIA EXTRACT; GARLIC EXTRACT; GINGER EXTRACT; GLYCYRRHIZA GLABRA EXTRACT; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOH BHASAM; MEDOHAR GUGGULU; PIPER LONGUM EXTRACT; PLANT EXTRACT; RADISH EXTRACT; SUDH SHILAJEET; SYZYGIUM CUMINI EXTRACT; TERMINALIA ARJUNA EXTRACT; TRIACYLGLYCEROL; TRIGONELLA FOENUM GRAECUM EXTRACT; TRIKATU; TRIMURTI; TRIPHALA; TYLOXAPOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIDANGADI LAUHA;

AEGLE; AEGLE MARMELOS; ANIMAL EXPERIMENT; ARTICLE; ASPHALTUM PUNJABIUM; BOERHAAVIA DIFFUSA; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; CYAMPOSIS PSORALIODES; DRUG ACTIVITY; EMBELIA; EMBELIA RIBES; EUGENIA; HYPERLIPIDEMIA; HYPOLIPEMIA; MALE; MEDICINAL PLANT; NONHUMAN; PIPER LONGUM; RADISH; RAT; SYZYGIUM CUMINI; TERMINALIA; TERMINALIA ARJUNA; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 38349065120     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Holzgartner J, Schmidt U, Kuhn U. Comparison of the efficacy of garlic preparation vs bezafibrate. Arzneim-Forsch Drug Res. 1992; 42: 1473-77.
2. Agarwal RC, Singh SP, Saran RK. Clinical trial of guggul lipid new hypolipidemic agent of plant origin in primary hyperlipidaemia. Indian J Med Res. 1986; 84: 626-34.
3. Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid - A new hypolipidemic agent. J Assoc Phys India. 1989; 37: 323-28.
4. Xue WL, Li XS, Zhang J, Liu YH, Wang ZL, Zhang RJ. Effect of Tnigonella foenum- graecum (fenugreek) extract on blood glucose, blood lipid and hemorheological properties in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr. 2007; 16: 422-426.
5. U.C.Datta and G. King, Materia Medica of the Hindus. Machine Press, Calcutta, India, 1877; pp.33-37.
6. Ali Taghizadeh Afshari, Alireza Shirpoor, Amirabbas Farshid, Ramm Saadatian, Yousef Rasmi, Ehsan Saboory, Behrooz Ilkhanizadeh and Abdolamir Allameh. The effect of ginger on diabetic nephropathy, plasma antioxidant capacity and lipid peroxidation in rats. Food Chemistry, 2007; 101: 148-153
7. Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Antidiabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats.Br J Nutr. 2006; 96: 660-666.
8. Suchandra Chatterjee, Zareena Niaz, S. Gautam, Soumyakanti Adhikani, Prasad S. Variyar and Arun Sharma. Antioxidant activity of some phenolic constituents from green pepper (Piper nigrum L.) and fresh nutmeg mace (Myristica fragrans).Food Chemistry. 2007; 101: 515-523.
9. Rakesh K. Johri, Neelima Thusu, Annu Khajuria and Usha Zutshi. Pipenine-mediated changes in the permeability of rat intestinal epithelial cells: The status of γ-glutamyl transpeptidase activity, uptake of amino acids and lipid peroxidation. Biochemical Pharmacology. 1992; 43: 1401-1407.
10. Vogel H G and Vogel W H. Drug Discovery and Evaluation Pharmacological assays,Spiinger Verlag, Berlin, 1997; pp.598.
11. Miller G J and Miller N E. Plasma- HDL Concentration and development of Ischaemic Heart Disease, Lancet. 1975; 1: 16-19.
12. Gotto AM Jr, LaRosa JC, Hunninghake D. The cholesterol facts. A summary of the evidence relating dietary facts, serum cholesterol and coronary heart disease, Circulation. 1990; 81: 1721-33.
13. Leren P. The Oslo. Diet Heart Study: eleven-year report. Circulation. 1970; 42: 935-42.
14. Buchwald H, Varco RL, Matts JP. Effect of partial ileal bypass on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia-report of the program on the Surgical Control of Hyperlipidaemias (POSCH). N Engl. J. Med. 1990; 323: 946-55.
15. Tiwari, A.K., Agrawal, A., Gode, J.D. and Dubey, G.P.(1991) "A prospective randomised crossover study of propranolol and Abana in hypertensive patients: Effect of lipids and lipoproteins. The Antiseptic. 1991; 88: 41.